“The BIG team knows how to bring in a set of sharp & differentiated insights with a solid exploration of the unknown. I never expected them to have such an unparalleled depth of knowledge in the subject. The frameworks, unique questions, rigour to explore the 'why' and phenomenal passion to deliver market feasible solutions... which makes BIG such an effective partner to work with. I took the outputs and grilled them through quant validation and it’s true that the recommended ones were the only successful ones.”
INSIGHTS & ANALYTICS DIRECTOR, GSK
Creating a new category with China and India as the pilot markets.
"Internally we all feel that we couldn't have achieved what we have without your brilliant crafting and inferences about the consumer insights and the related product portfolio."
EMERGING MARKETS ACCELERATION TEAM
We’ve been trying over the past 5 years to develop a brand to compete in the growing natural healthcare market, but as leader in allopathic medicine we are struggling to find a credible and distinctive proposition.
How to redefine what natural healthcare means for a new generation of consumers, starting with the heartland of Ayurveda in India and Chinese Medicine.
How to turn a traditional lifestyle commitment, into a 21st Century wellbeing reality.
A new brand for GSK in naturals, with an innovation pipeline of five new territories in the Indian market, all equally relevant to a global audience.
83% of the recommended concepts achieved trial indices in the top 5% ever recorded in the GSK research database.
The success saw the initiative escalated to a top global priority.
In 2021 we continue to collaborate with GSK India on the winning launch communication strategy.